Exelixis Announces Webcast of January 15 Presentation at the J.P....
Exelixis, Inc. today announced that Michael M. Morrissey, Ph.D., the company's president and chief executive officer, will present at the J.P. Morgan 32nd Annual Healthcare Conference at 5:00 p.m. EST / 2:00 p.m. PST on Wednesday, January 15, 2014, in San Francisco.
Stocks to Track - Gray Television, Inc. (NYSE:GTN), Aruba Networks,...
Value Penny Stocks issues special report on Gray Television, Inc. , Aruba Networks, Inc. , Forest Oil Corporation , Exelixis, Inc. .
Exelixis, Inc. Initiates Randomized Phase 2 Clinical Trial Of...
Exelixis, Inc. today announced that it has initiated a phase 2 clinical trial comparing cabozantinib plus abiraterone and prednisone versus abiraterone/prednisone in patients with castration-resistant prostate cancer who have bone metastases and have not been previously treated with chemotherapy.
Exelixis Announces Webcast of December 3 Presentation at the 25th...
Exelixis, Inc. today announced that Michael M. Morrissey, Ph.D., the company's president and chief executive officer, will present at the 25th Annual Piper Jaffray Healthcare Conference at 10:30 a.m. EST/7:30 a.m. PST on Tuesday, December 3, 2013 in New York.
Stocks to Watch - RadioShack Corporation (NYSE:RSH), Antares Pharma...
StockMarketIntel.com issues a special report on the following stocks: RadioShack Corporation , Antares Pharma Inc , Exelixis, Inc. , LDK Solar Co., Ltd RadioShack Corporation gained 3.64%, trading on 1.97 million shares, to end the trade at $2.85.